$1.97
0.021.03%
At Close: -
$2.00
0.031.52%
After Hours: 4:30 PM EDT
15 minutes delayed
iBio
IBIOAMEX
iBio (AMEX:IBIO) Stock, Analyst Ratings, Price Targets, Predictions
iBio Inc has a consensus price target of $1.72, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Chardan Capital, Chardan Capital, and Cantor Fitzgerald on June 3, 2024, May 28, 2024, and October 7, 2022. With an average price target of $3.39 between Chardan Capital, Chardan Capital, and Cantor Fitzgerald, there's an implied 69.50% upside for iBio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
JMP Securities
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for iBio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/03/2024 | Buy Now | 150% | Chardan Capital | Keay Nakae | $5 → $5 | Maintains | Buy | Get Alert |
| 05/28/2024 | Buy Now | 150% | Chardan Capital | Keay Nakae | → $5 | Initiates | → Buy | Get Alert |
| 02/16/2023 | Buy Now | — | JMP Securities | Roy Buchanan | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 10/07/2022 | Buy Now | -91.5% | Cantor Fitzgerald | Kristen Kluska | $1250 → $85 | Downgrade | Overweight → Neutral | Get Alert |
| 11/29/2021 | Buy Now | -25% | JMP Securities | Roy Buchanan | → $750 | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for iBio (IBIO) stock?
The latest price target for iBio (AMEX:IBIO) was reported by Chardan Capital on June 3, 2024. The analyst firm set a price target for $5.00 expecting IBIO to rise to within 12 months (a possible 150.00% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for iBio (IBIO)?
The latest analyst rating for iBio (AMEX:IBIO) was provided by Chardan Capital, and iBio maintained their buy rating.
When was the last upgrade for iBio (IBIO)?
There is no last upgrade for iBio
When was the last downgrade for iBio (IBIO)?
The last downgrade for iBio Inc happened on February 16, 2023 when JMP Securities changed their price target from N/A to N/A for iBio Inc.
When is the next analyst rating going to be posted or updated for iBio (IBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of iBio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for iBio was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.
Is the Analyst Rating iBio (IBIO) correct?
While ratings are subjective and will change, the latest iBio (IBIO) rating was a maintained with a price target of $5.00 to $5.00. The current price iBio (IBIO) is trading at is $2.00, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.